• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.

作者信息

Mayall F, Rutty K, Campbell F, Goddard H

机构信息

Lancaster Moor Hospital, UK.

出版信息

Histopathology. 1994 Mar;24(3):211-4. doi: 10.1111/j.1365-2559.1994.tb00512.x.

DOI:10.1111/j.1365-2559.1994.tb00512.x
PMID:8200622
Abstract

The histogenesis of carcinosarcomas has intrigued pathologists for a long time and remains unresolved. Two main theories have been put forward, one suggesting that they are monoclonal, another suggesting that they are biclonal. Our study examined p53 immunostaining in 17 uterine carcinosarcomas (mixed Müllerian tumours) and found positivity in five (30%). There was no disparity in immunostaining between the epithelial and the stromal components in any of the 17 tumours. This concordance in every tumour would be very unlikely if carcinosarcomas are biclonal. However, it would be expected if carcinosarcomas are monoclonal.

摘要

相似文献

1
p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.
Histopathology. 1994 Mar;24(3):211-4. doi: 10.1111/j.1365-2559.1994.tb00512.x.
2
Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.子宫和卵巢的癌肉瘤(恶性苗勒管混合瘤):一项特别涉及组织发生的遗传学研究
Int J Gynecol Pathol. 2003 Oct;22(4):368-73. doi: 10.1097/01.pgp.0000092134.88121.56.
3
Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.子宫癌肉瘤的分子标志物与临床行为:重点关注上皮性肿瘤成分。
Mod Pathol. 2011 Oct;24(10):1368-79. doi: 10.1038/modpathol.2011.88. Epub 2011 May 13.
4
Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.子宫癌肉瘤:临床、组织病理学及免疫组织化学特征
Int J Gynecol Pathol. 2017 Sep;36(5):412-419. doi: 10.1097/PGP.0000000000000346.
5
DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.DNA错配修复和TP53缺陷是子宫癌肉瘤肿瘤发生过程中的早期事件。
Mod Pathol. 2006 Oct;19(10):1333-8. doi: 10.1038/modpathol.3800654. Epub 2006 Jun 30.
6
Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).p53信号通路改变在子宫癌肉瘤(恶性混合性苗勒管肿瘤)中的作用。
Oncology. 2014;87(4):193-204. doi: 10.1159/000363574. Epub 2014 Jul 11.
7
Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.子宫癌肉瘤(恶性混合性苗勒管肿瘤):生物学和临床特征阐释的进展
J Natl Compr Canc Netw. 2009 May;7(5):550-6; quiz 557. doi: 10.6004/jnccn.2009.0037.
8
Uterine carcinosarcoma is derived from a single stem cell: an in vitro study.
Int J Cancer. 1997 Sep 4;72(5):821-7. doi: 10.1002/(sici)1097-0215(19970904)72:5<821::aid-ijc19>3.0.co;2-b.
9
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components.女性生殖道癌肉瘤(恶性混合性苗勒管肿瘤):上皮和间充质成分的比较分子分析
Hum Pathol. 1998 Jan;29(1):82-7. doi: 10.1016/s0046-8177(98)90394-x.
10
Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.子宫癌肉瘤的预后因素:25例患者的临床病理研究
Cancer. 1998 Feb 1;82(3):512-9.

引用本文的文献

1
Carcinosarcoma of the Endometrium-Pathology, Molecular Landscape and Novel Therapeutic Approaches.子宫内膜癌肉瘤——病理学、分子格局与新型治疗方法
Medicina (Kaunas). 2025 Jun 26;61(7):1156. doi: 10.3390/medicina61071156.
2
Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review.伴有腹膜后腹主动脉旁淋巴结转移的卵巢癌肉瘤及罕见术后并发症:一例报告并文献综述
Diagnostics (Basel). 2020 Dec 11;10(12):1073. doi: 10.3390/diagnostics10121073.
3
miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
miR-200c 驱动的间质-上皮转化是子宫癌肉瘤的治疗靶点。
Sci Rep. 2017 Jun 15;7(1):3614. doi: 10.1038/s41598-017-03972-7.
4
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.一项关于I - III期子宫癌肉瘤预后的多机构研究。
Gynecol Oncol. 2015 Nov;139(2):275-82. doi: 10.1016/j.ygyno.2015.09.002. Epub 2015 Sep 6.
5
Which is worse: uterine papillary serous carcinomas or carcinosarcomas?哪种更糟糕:子宫乳头状浆液性癌还是癌肉瘤?
J Gynecol Oncol. 2011 Jun 30;22(2):83-8. doi: 10.3802/jgo.2011.22.2.83.
6
Primary malignant mixed müllerian tumor of the peritoneum a case report with review of the literature.原发性腹膜恶性混合苗勒管肿瘤 1 例报告并文献复习
World J Surg Oncol. 2011 Feb 4;9:17. doi: 10.1186/1477-7819-9-17.
7
Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.卵巢和子宫癌肉瘤的分子遗传学畸变——一项比较基因组杂交和荧光原位杂交研究
Virchows Arch. 2008 Mar;452(3):259-68. doi: 10.1007/s00428-007-0557-6.
8
Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report.起源于卵巢皮样囊肿的单克隆性癌肉瘤:一例报告
BMC Cancer. 2006 Mar 1;6:47. doi: 10.1186/1471-2407-6-47.
9
Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?恶性双相性子宫肿瘤:癌肉瘤还是化生癌?
J Clin Pathol. 2002 May;55(5):321-5. doi: 10.1136/jcp.55.5.321.
10
The clonal origin and clonal evolution of epithelial tumours.上皮性肿瘤的克隆起源与克隆进化
Int J Exp Pathol. 2000 Apr;81(2):89-116. doi: 10.1046/j.1365-2613.2000.00142.x.